Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-10-12
2009-06-23
Saoud, Christine J (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000, C530S399000
Reexamination Certificate
active
07550435
ABSTRACT:
Isolated omentin polypeptides that selectively express in omental fat tissue and methods for the use of the polypeptides. The polypeptides can be used in a method for modifying insulin action and/or glucose metabolism in an animal. The polypeptides can be used to promote glucose uptake by animal adipocytes and other cells, tissues, and/or organs. The polypeptides can also used to provide a therapeutic treatment for diseases of or related to glucose metabolism and adipose tissues. The polypeptides are also incorporated into diagnostic tests and testing kits for diagnosing or detecting a disease or condition involving animal tissue that contains, uses, or expresses the polypeptide in an animal suspected of having the disease or condition.
REFERENCES:
patent: 6146849 (2000-11-01), Pierce et al.
patent: 6342581 (2002-01-01), Rosen et al.
patent: 6478825 (2002-11-01), Winterbottom et al.
patent: 6635255 (2003-10-01), Bruck et al.
patent: 7022493 (2006-04-01), Issakani et al.
patent: 2002/0173635 (2002-11-01), Jacobs et al.
patent: 2003/0064412 (2003-04-01), Fischer et al.
patent: 2003/0082533 (2003-05-01), Yue et al.
patent: 2004/0044191 (2004-03-01), Fischer et al.
patent: 2004/0220099 (2004-11-01), Gong et al.
patent: 2005/0032166 (2005-02-01), Chen et al.
patent: 2005/0112675 (2005-05-01), Kochan et al.
patent: 99/49033 (1999-09-01), None
patent: 99/60161 (1999-11-01), None
patent: 00/05367 (2000-02-01), None
patent: 00/66708 (2000-11-01), None
patent: 00/73454 (2000-12-01), None
patent: 01/16318 (2001-03-01), None
patent: 01/68848 (2001-09-01), None
patent: 02/068579 (2002-09-01), None
Yang et al., “cDNA Cloning, Genomic Structure, Chromosomal Mapping, and Functional Expression of a Novel Human Alanine Aminotransferase,” Genomics, Mar. 2002, 79(3), pp. 445-450.
Kashiwagi et al., “In Vitro Insulin Resistance of Human Adipocytes Isolated From Subjects with Noninsulin-Dependent Diabetes Mellitus,” J. Clin. Invest., Oct. 1983, 72(4), pp. 1246-1254.
Tsuji et al., “Human Intelectin is a Novel Soluble Lectin That Recognizes Galactofuranose in Carbohydrate Chains of Bacterial Cell Wall,” The Journal of Biological Chemistry, Jun. 2001, 276(26), pp. 23456-23463.
Lee et al., “Human Homologs of the Xenopus Oocyte Cortical Granule Lectin XL35,” Glycobiology, 2001, 11(1), pp. 65-73.
Suzuki et al., “Molecular Cloning and Functional Expression of a Human Intestinal Lactoferrin Receptor,” Biochemistry, 2001, 40, pp. 15771-15779.
Komiya et al., “Cloning of the Novel Gene Intelectin, Which is Expressed in Intestinal Paneth Cells in Mice,” Biochemical and Biophysical Research Communication, 1998, 251, pp. 759-762.
Altschul et al., Gapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programs, Nucleic Acids Research, 1997, 25, pp. 3389-3402.
NCBI Database Accession No. AAS49907, May 19, 2006.
Yang et al., Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action.Am J Physiol Endocrinol Metab290: E 1253-E1261, 2006.
De Souza Batista et al., Omentin Plasma Levels and Gene Expression Are Decreased in Obesity.Diabetes56:1655-1661 (2007).
Gong Da-Wei
McLenithan John
Shuldiner Alan
Yang Rongze
Merchant & Gould
Saoud Christine J
University of Maryland Baltimore
LandOfFree
Method of modifying glucose activity using polypeptides... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of modifying glucose activity using polypeptides..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of modifying glucose activity using polypeptides... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4087726